鼻咽癌远处转移分子标志物的筛选及其预测模型的构建
批准号:
81572912
项目类别:
面上项目
资助金额:
57.0 万元
负责人:
陈明远
依托单位:
学科分类:
肿瘤诊断
结题年份:
2019
批准年份:
2015
项目状态:
已结题
项目参与者:
罗东华、华贻军、张孟霞、江柔、邹雄、游瑞、卢佳斌、魏灯辉、叶树标
中文摘要
远处转移是鼻咽癌的主要死因,难点之一在于缺乏准确预测鼻咽癌转移的分子标志物。目前多采用血浆筛选分子标志物,但由于成分复杂,难以发现低丰度标志物。近期研究证实,血浆外泌体中可检测到疾病相关的低丰度蛋白。我们前期研究证明血浆外泌体与鼻咽癌远处转移密切相关,并通过质谱技术对鼻咽癌远处转移和非转移患者的血浆外泌体进行蛋白定量分析,成功筛选出差异表达蛋白34个,其中解旋酶DHX58表达差异最显著。细胞功能实验证实DHX58与鼻咽癌侵袭转移能力密切相关,Elisa法检测临床血浆标本发现DHX58预测鼻咽癌转移的准确度达70%。本项目拟进一步筛选其它外泌体转移相关蛋白,并通过随机生存树数学算法,构建一个由DHX58和其它标志物共同组成的转移预测模型,最大程度优化预测精度,并采用来源于前瞻性临床试验的大样本血标本进行验证,为早期预测鼻咽癌转移提供可靠的预测模型,为临床个体化治疗和诊断试剂盒研发提供理论依据
英文摘要
Distant metastasis is the major cause of death in nasopharyngeal carcinoma (NPC). One of the key reasons is a lack of biomarkers of NPC to predict the distant metastasis accurately. At present, hematologic specimens was routinely used to screen molecular markers but usually failed to find it with low abundance because the blood is an extremely complex biological samples, including more than 1,000,000 protein species. However, previous studies had showed that enriched plasma exosomes is helpful to find these low abundance biomarkers. Furthermore, we have demonstrated that the plasma exosomes are closely related with the distant metastasis of NPC. Therefore, we performed a quantitative analysis of proteins in plasma exosomes in NPC patients with distant metastasis vs. non-metastasis and successfully screened out 34 proteins with significantly differentially expression using the technology of SWATH mass spectrometry quantitative proteomic analysis method. Among those 34 protein, the expression of helicase DHX58 had most significant difference. Further cell experiments confirmed that DHX58 is closely related to the ability of invasion and metastasis of NPC cell. DHX58 is also proved to be efficient in predicting the distant metastasis with sensitivity and specificity of 68.6% and 71.4% based on plasma specimens with clinic data using Elisa method. This project aims to further screen out the rest exosome proteins associated tumor metastasis and set up a prediction Model for distant metastasis of NPC based on DHX58 and other metastasis-associated molecular markers to optimize prediction accuracy using random tree algorithm on survival. Finally, the prediction Model will be validated by large sample of blood specimen based on prospective clinical trials. This project will provide a promising and reliable prediction model for metastasis in NPC and theoretical basis for the development of the corresponding diagnostic kit.
远处转移是鼻咽癌的主要死因,难点之一在于缺乏准确预测鼻咽癌转移的分子标志物。研究发现,外泌体在肿瘤转移过程中起着桥梁的作用,血浆外泌体中可检测到疾病相关的低丰度蛋白,有望成为液体活检的目标。我们前期研究证明血浆外泌体与鼻咽癌远处转移密切相关,并通过质谱技术对鼻咽癌远处转移和非转移患者的血浆外泌体进行蛋白定量分析,成功筛选出差异表达蛋白34个,并证实外泌体DHX58、M2BP等蛋白参与调控鼻咽癌侵袭转移。此外,我们发现自噬相关蛋白SQSTM1与鼻咽癌远处转移密切相关,联合鼻咽癌诊断TNM分期的N分期,构建SQSTM1/N转移预测模型模型,可有效地筛选出诱导化疗受益人群,并将其治疗增益比提高了7 倍,有望实现鼻咽癌的精准化疗。依托本项目,发表第一作者/通讯作者论文14 篇,其中SCI 收录期刊论文14篇,分别为: Cancer Research(IF: 8.378,1篇)、Theranostics(IF: 8.063,共2篇)、International Journal of Cancer(IF: 7.36,1篇)、European Journal of Cancer(IF: 7.191,共3篇)、Oral Oncology(IF: 4.636,共2篇)、Cancer Communications(IF: 3.62,共2篇)、BMC Cancer (IF: 3.288,1篇)、Laryngoscope (IF: 2.422,共2篇)。 基于本项目的研究发现,项目申请人继续作为主持人获得各级科研项目资助5项,总经费达675万元,并入选第四批国家“万人计划”科技创新领军人才、科技部创新人才推进计划中青年科技创新领军人才以及广东省“杰出青年医学人才”。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
诱导化疗后同步放化疗与单独同步放化疗治疗局部晚期鼻咽癌:III 期多中心随机对照试验的长期结果
DOI:
10.1016/j.ejca.2019.07.007
发表时间:
2019-09-01
期刊:
EUROPEAN JOURNAL OF CANCER
影响因子:
8.4
作者:
[Yang, Qi, Cao, Su-Mei, Chen, Ming-Yuan]
通讯作者:
Chen, Ming-Yuan
Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma
单纯微创手术与调强放疗治疗I期鼻咽癌的比较
DOI:
10.1186/s40880-019-0415-3
发表时间:
2019-11-15
期刊:
CANCER COMMUNICATIONS
影响因子:
16.2
作者:
[Liu, You-Ping, Lv, Xing, Chen, Ming-Yuan]
通讯作者:
Chen, Ming-Yuan
Clonal Mutations Activate the NF-κB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma
克隆突变激活 NF-κB 通路促进鼻咽癌复发
DOI:
--
发表时间:
2019
期刊:
cancer research
影响因子:
11.2
作者:
[Ming-Yuan Chen, Rui You]
通讯作者:
Rui You
Proposal for a new risk classification system for nasopharyngeal carcinoma patients with post-radiation nasopharyngeal necrosis
针对鼻咽癌放射后鼻咽坏死患者建立新的风险分类系统的建议
DOI:
10.1016/j.oraloncology.2017.02.012
发表时间:
2017-04-01
期刊:
ORAL ONCOLOGY
影响因子:
4.8
作者:
[Yang, Qi, Zou, Xiong, Chen, Ming-Yuan]
通讯作者:
Chen, Ming-Yuan
Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up.
II-IVb 期鼻咽癌同步放化疗联合或不联合抗 EGFR 靶向治疗:大队列和长期随访的回顾性分析
DOI:
10.7150/thno.19710
发表时间:
2017
期刊:
Theranostics
影响因子:
12.4
作者:
[You R, Hua YJ, Liu YP, Yang Q, Zhang YN, Li JB, Li CF, Zou X, Yu T, Cao JY, Zhang MX, Jiang R, Sun R, Mo HY, Guo L, Cao KJ, Lin AH, Sun Y, Qian CN, Ma J, Chen MY]
通讯作者:
Chen MY
共 14 条
PALD1基因多态性调控血管内皮损伤促进放射性鼻咽坏死的作用及其机制研究
-
批准号:82261160399
-
项目类别:重点项目
-
资助金额:262万元
-
批准年份:2022
-
负责人:陈明远
-
依托单位:
基于血浆EBV DNA 和EBV抗体的鼻咽癌早期筛查及策略优化
-
批准号:--
-
项目类别:--
-
资助金额:100万元
-
批准年份:2022
-
负责人:陈明远
-
依托单位:
p62/SQSTM1通过wnt/β-catenin通路促进鼻咽癌转移的分子机制
-
批准号:81772895
-
项目类别:面上项目
-
资助金额:45.0万元
-
批准年份:2017
-
负责人:陈明远
-
依托单位:
三维细胞培养模拟临床缺氧状态下HIF-1a转录调节Aurora激酶诱发鼻咽癌放疗抵抗的分子机制
-
批准号:81071890
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:陈明远
-
依托单位:
国内基金
海外基金